playtoearnnftgame|蓝帆医疗：子公司一次性使用冠脉血管内冲击波导管获得中国NMPA注册

News summary

[Lanfan Medical: The subsidiary's single-use intravascular coronary shock wave catheter obtained NMPA registration in China] Securities Times e Company Newsplaytoearnnftgame, Lanfan Medical (002382) announced on the evening of May 27 that the company's Cardiovascular and Cardiovascular Business DepartmentplaytoearnnftgameShanghai Lanfan Boyuan Medical Technology Co., Ltd., a subsidiary of its subsidiary, independently developed andplaytoearnnftgame.playtoearnnftgame..

Newsletter text

[Lanfan Medical: The subsidiary's single-use intravascular shock wave catheter has been registered with China's NMPA] Securities Times e Company News, Lanfan Medical (002382) announced on the evening of May 27 that Shanghai Lanfan Boyuan Medical Technology Co., Ltd., a subsidiary of the company's Cardiovascular and Cardiovascular Business Department, has obtained approval and registration of the three types of medical device products independently developed and produced by the State Drug Administration (NMPA).